PV

Perumal Viyash

Active Director Additional Director DIN 08350502
DIN 08350502 First appointment Mar 2019 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 2 historical roles
Total affiliations 5 Since Mar 2019
Shareholding value •••• Premium profile

About Perumal Viyash

Data last updated:

Perumal Viyash is an Additional Director at Transworld Medical Corporation Private Limited (since 2024), Director at Binny Mills Limited (since 2024) and Director at Transworld Enterprises And Infrastructure Private Limited (since 2026). The companies operate in Pharma, Financial Services and Chemicals. The 2 current companies with reported revenue have a combined latest revenue of ₹72.62 Cr; the largest is Transworld Medical Corporation Private Limited at ₹65.39 Cr (FY 2024). Earlier, Perumal Viyash was an Additional Director at Ramachandra Pharmaceuticals Private Limited (2024–2025) and Director at Sri Ramachandra Diagnostic Private Limited (from 2019).

DIN 08350502
Primary Designation Additional Director
Industry Pharma
First Appointment 07 Mar 2019
Oldest Company Age 18 yrs
Largest company Transworld Medical Corporation Private Limited · ₹65.39 Cr (FY 2024)
Combined revenue ₹72.62 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director23 May 20242012₹65.39 Cr (FY 2024)Active
Binny Mills Limited L17120TN2007PLC065807
Director24 May 20242007₹7.24 Cr (FY 2025)Active
Director05 Aug 20262026Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director23 May 20242019Active
Director07 Mar 20192019Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Sri Ramachandra Diagnostic Private Limited
Binny Mills Limited
Transworld Medical Corporation Private Limited
Transworld Enterprises And Infrastructure Private Limited
Premium access

Shareholding and investment profile for Perumal Viyash

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Perumal Viyash

Perumal Viyash currently holds 3 directorships: Transworld Medical Corporation Private Limited (Additional Director, since 23 May 2024, revenue ₹65.39 Cr (FY 2024)); Binny Mills Limited (Director, since 24 May 2024, revenue ₹7.24 Cr (FY 2025)); Transworld Enterprises And Infrastructure Private Limited (Director, since 05 Aug 2026).

Perumal Viyash was first appointed on 07 Mar 2019 as Director at Sri Ramachandra Diagnostic Private Limited. The most recent appointment on record is 05 Aug 2026 at Transworld Enterprises And Infrastructure Private Limited.

The 2 current companies of Perumal Viyash that report revenue have a combined latest revenue of ₹72.62 Cr: Transworld Medical Corporation Private Limited ₹65.39 Cr (FY 2024); Binny Mills Limited ₹7.24 Cr (FY 2025).

Perumal Viyash held 2 earlier board appointments: Ramachandra Pharmaceuticals Private Limited (Additional Director, 23 May 2024 to 01 Oct 2025); Sri Ramachandra Diagnostic Private Limited (Director, from 07 Mar 2019).

The current boards of Perumal Viyash's companies include Ramachandran Thillainayagam (Transworld Medical Corporation Private Limited), Sengutuvan Venkataachalam (Transworld Medical Corporation Private Limited), Aarthi Kannan (Binny Mills Limited), Ashwath Naroth (Binny Mills Limited), Ganesan Geetha (Binny Mills Limited), Kannan (Binny Mills Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available